Informa Connect Singapore is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Register your interest


Register your interest


Vaccines and Therapeutics

28 – 30 October 2020, Delivered Digitally

Book Now Register Your Interest

Early Bird Rate: Register & Pay by 4 September 2020


Addressing the Need for Speed COVID-19 Trials, BioProcess Development, Manufacturing and Commercialisation 

Vaccines and Therapeutics 2020 GOES VIRTUAL 

Delivered digitally to help manage travel and physical distancing restrictions, the organising committee for Vaccines and Therapeutics Conference is delighted to present an innovative and creative format for the event.    

Repurposed to address the emerging and likely permanent shifts developing vaccines for COVID-19 and other novel diseases in the pharma and life sciences industry. The content will be practical and strategic. Immediate COVID related solutions will be balanced with a longer-term industry outlook against the entire drug landscape. 

Your health and safety is our priority. 

In light of the ongoing COVID-19 outbreak, we are actively monitoring the situation. After extensive consultation with our partners, we have decided to host the conference online.

Learn More About COVID-19 Advisory from Informa >


Conference Highlights

Gain access to simultaneous streams of live content across three days of the conference along with quality matchmaking opportunities!

Hear from our global pharmaceutical, biotech, government vaccines development and more experts live and schedule your sessions with a virtual agenda, completely customisable to opt into any panels offered across our two days event.


With intent based and AI powered virtual matchmaking, you will meet quality leads over 1:1 meetings to make meaningful connections.


We will provide full access for you to view our quality content on demand for up to three months after the event ends so that you don’t miss out on any session.


A virtual showcase of players in the industry for you to view product demos, network and take your business to the next level. 


Global Manufacturing Capabilities

Chairperson’s Opening Remarks

  • Speeding development timeline
  • Meeting nimble manufacturing capacity
  • Moving from manufacturing to access
  • Managing critical supply chain and logistics deliverables

1:30 pm

  • Clinical trials update – Progressing in late-stage
  • Increasing manufacturing capacity
  • Managing regulations and candidate efficacy
  • Safety protocol and vigorously monitoring outcomes
  • The case of Ad5-nCoV

2:00 pm

  • CEPI’s role in accelerating alliance, partnership, funding and developing safe vaccines
  • Overview of COVID-19 investments
  • Expanding and enabling manufacturing capabilities
  • Ensuring access, affordability and supply
  • What can we expect next?

2:30 pm

Networking and Stretch Break

3:50 pm

Accelerating Vaccines Development

  • Managing crisis and opportunities during COVID-19
  • How to adapt and adjust antibodies developments
  • Overcoming the different risks for vaccines

4:20 pm

  • Overview of the therapeutic antibody discovery landscape
  • Challenges of classical approaches to monoclonal antibodies (mAb) discovery
  • Major benefits of Hummingbird’s approach using its proprietary rational antibody discovery (RAD) platform
  • Successes in developing antibodies recognizing precise epitopes on both HER3 and VISTA

4:50 pm

5:20 pm

6:00 pm

Chairperson’s Summary and End of Day 1

R&D Innovate

Chairperson’s Opening Remarks

2:00 pm

  • Potential of tackling viral diversities
  • Data collection for safety and efficacy
  • Ensuring rapid scalability of candidate

2:30 pm

Online Networking and Stretch Break

3:00 pm

  • Collaborating technology in search of cures
  • How AI has been leveraged in the search for optimal drug combinations to treat COVID-19 patients
  • How does IDentif.AI platform make precise recommendations based on dosage and mix
  • Key process implementations and what are the challenges faced
  • Success rate and key takeaways

3:30 pm

Vaccines Trials and COVID-19

4:20 pm

  • Accelerating clinical trials
  • From India to the rest of the world
  • Upscaling production of candidate

4:50 pm

  • Effective evidence generation strategies
  • Expediting candidate approval processes
  • Correcting misinformation for vaccine use through evidence

5:20 pm

  • Optimising R&D efficiency and speeding up access to patients through big data
  • Effective use of big data analytics and how it helps to learn about the virus progresses among diverse patient populations
  • What is the paradigm shift towards value and outcomes in the healthcare and pharma system?

6:00 pm

Chairperson’s Summary and End of Day 2

Partnerships and Alliances

Chairperson’s Opening Remarks

  • Balancing HIV and COVID candidate’s development
  • International data sharing to bridge knowledge gap
  • Working together for vaccines deployment

1:30 pm

  • Investors’ evolving expectations
  • Understanding operational capabilities for value proposition
  • Managing portfolio investments

2:00 pm

  • Innovation and developing cancer vaccines
  • Collaboration for Agile Pharma
  • Expanding pipelines and technology

2:30 pm

Online Networking and Stretch Break

3:30 pm

  • Supply meeting demand: How to ensure sufficient supplies for the world
  • Strategies to improve operational efficiency for supply chain
  • Optimising vaccine distribution for the public
  • Collaboration with stakeholders for speedy vaccines production

4:15 pm

  • Critical procurement decision-making
  • Advancements in technology and R&D
  • Coordinating with international bodies for vaccines supply security
  • Working away from inward policy trends for better vaccines distribution

5:00 pm

Chairperson’s Summary and End of Day 3


Packages Price
Live Online Experience - Pharma, Biotech Companies RateSGD $1795Early Bird
Live Online Experience - Industry RateSGD $2095Early Bird
Start-Up RateSGD $495Early Bird

Early Bird Rate: Register & Pay by 4 September 2020

Special Institutional Rate:
Register 50 Passes At A Fixed Price of SGD $8,995

Group Rate
Pharma, Biotech Companies Rate
Group of 3 or more: SGD 1, 195 (Early Bird Rate), SGD 1, 295 (Normal Rate)

Industry Rate
Group of 3 or more: SGD 1,495

For Group Registrations,
email or call +65 6508 2477


  • Multiple Bookings Discount pricing is applicable to groups of 3 or more delegates from the same organisation registering for the same event, at the same time.
  • Fee stated is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR group rate.
  • All delegates from Singapore-based companies are required to pay an additional 7% GST (SINGAPORE EVENTS ONLY)

About the conference

Vaccines and Therapeutics Conference  

The race is on to find vaccines and therapeutics to stop the spread of the COVID-19 virus, besides other novel diseases. Global scientific community, pharmaceuticals, biotech, and governments around the world are researching different vaccine technologies that might halt the pandemic at the accelerated speed.  

The inaugural Vaccines and Therapeutics Conference is a global gathering anddelivered digitally.  

The conference envisions the outlook for current vaccines candidacy analysis, R&D and trials insights, private sector investment showcases, government grants and incentives, outlines strategies to scaling up manufacturing and centre staging technological advancements. Furthermore, vaccines safety, speed to market, affordability, and commercial viability that are pivotal part of vaccine development.  


In Discussion: 

  • COVID-19 Vaccines Development and R&D Showcase
  • Accelerating COVID-19 Discovery and Manufacturing
  • Key Insights on Trials, Bioprocessing and Commercialisation
  • Boosting Capacity of Large-Scale Vaccine Manufacturing
  • Global Collaboration, Alliances and Consortiums Showcases
  • Investing and Financing Vaccines and Therapeutics Candidates
  • Licensing, Speed to Market and Access
  • During/Post Vaccines Manufacturing Supply Chain Insights and Compliance
  • Vaccine Safety and Production Optimisation
  • Antibody Treatments and Immunotherapy
  • Re-engineering Existing Epidemic Candidates for COVID-19
  • Global Outlook for Coronavirus and other Novel Diseases


Conference Highlights

30+ Global Experts
With Education & Market Outlook Sessions

On Demand Content
Access sessions up to 3 months after the event

Accelerated Networking
With Intent Based and AI Powered Matchmaking

Elevated Engagement
Earlier, Longer and via A Seamless Dashboard

Program at a Glance

Day 1
28 October 2020 | Wednesday

Opening Address
R&D, and Vaccines Development

  • Global and Region vaccine development outlook
  • Accelerating research
  • Project case studies of vaccine candidates and project listing
  • Ensuring candidate safety and efficacy
  • Re-engineering existing epidemic candidates for COVID-19
  • Antibody treatments and Immunotherapy


Day 2
29 October 2020 | Thursday

Accelerated Vaccines Manufacturing  

  • Scaling up manufacturing for COVID-19
  • Boosting capacity for fast and mass-production
  • Manufacturing infrastructure and capacity
  • COVID Vaccines bioprocessing use cases
  • Manufacturing capacity, capability and investment in process and technology
  • Vaccine safety and production optimisation
  • CDMO’s presentations
  • Vaccines manufacturing outsourcing

Supply Chain

  • COVID-19 and disrupted supply chain
  • Vaccine distribution, critical supply and logistics
  • Preparing supply chain for coronavirus vaccines
  • Raw materials procurement insights
  • Packaging, distribution, and storage
  • Supply chain compliance


Day 3
30 October 2020 | Friday

Investment for Vaccines 

  • Responsible financing and investment
  • Expending vaccines portfolio and investment
  • COVID-19 related manufacturing infrastructure and process financing and investment
  • Government investment plans outlay
  • Investment showcases from pharmaceuticals, biotech and industry associations

Partnership and Alliances

  • Strategic partnerships and Consortium alliances
  • Speed to market and access
  • Sustainable financing, affordability and pricing
  • Licencing agreements
  • Alliances for production, procurement and distribution

Why Attend A Digital Event? 

Connect instantly with full visibility of the participant list via our secure and unique match making platform accessible to all participants, and integrated with the virtual conference

Knowledge and Engagement
Same content, but more interactive. Even more opportunities to reach out to fellow participants and speakers using specific tools in our virtual conference platform

Time-Efficient and Cost-Saving 
Save valuable time and money on travelling and accommodation

Focused and Timely Learning 
Receive the latest and most timely trends and figures from leading industry players at your convenience

With our On Demand Webcasts you can participate from any location, better plan your time and watch what you missed whenever you want


Unrivalled Opportunity to Profile your Company

Position your company in the networking heart of this event and create great connection with your attendees 

Thought leadership
Offer keynotes and educational sessions to you audience through live webinars or pre-recorded video broadcast with automated reminders, Q & A sessions and polls to keep your attendees engaged.

Informa Data+
Unique option for increased lead generation through retargeting of our global proprietary database in social media

Powerful Digital Matchmaking
Build valuable relationships with our intelligent matchmaking tool, live chat and integrated 1:1 video calls.

Virtual Booths
Online spaces with your brand identity, showcase your product demos, live chat with audiences. Manage your own logo, description video, collateral, staff profiles and more.

Focused Metrics
Measurable exposure and trackable meetings generate great ROI. Booth views, meeting requests, engagement rates – you’ll have all the data you need

Accelerated Brand Exposure
Gain prominence with focused digital theatres in the lead up, main conference days, and up to 3 months after the event with our on-demand content modules


Get in Touch to Find Out More About Digital Presence

For more information on digital sponsorship opportunities, please contact:

Yvonne Leong
+65 6508 2489,


If you are interested in exploring avenues for supporting this conference as a Media or Association Partner, please contact:

Jen Zhang
+65 6508 2463

Onboarding Sessions Available

To help attendees to better familiarize with the virtual platform, we are running onboarding sessions as follows:

26 October, 5 – 5.30pm SGT

Click here to register for your preferred timeslot, or email


Supply Chain Senior Representative, Johnson and Johnson, Singapore

Chao Shoubai

Chief Operating Officer, Cansino Therapeutics, China

Mike Whelan

Project Leader, CEPI, United Kingdom

Michael Agrez

Chief Executive Officer and Chief Scientific Officer, InterK Peptide Therapeutics Ltd, Australia

Gopinath Nageshwaran

Strategy and Planning Lead, Vaccine Epidemiology and Modelling, Sanofi, Singapore

Andreas Schmidt

Chief Executive Officer, Proteona, Germany

Jerome Boyd-Kirkup

Chief Scientific Officer, Hummingbird Bioscience, Singapore

Prof Nikolai Petrvsky

Research Director, Vaxine, Australia

Kayvon Modjarrad

Director, Emerging Infectious Diseases, US Military HIV Research Program, United States

Prof. Dean Ho

Provost’s Chair Professor of Biomedical Engineering and Pharmacology, Director of The N.1 Institute for Health (N.1), Director of Institute for Digital Medicine (WisDM), Department Head of Biomedical Engineering, National University of Singapore, Singapore

Dr Jean-Louis Excler

Program Director, New Initiatives, International Vaccine Institute, Republic of Korea

Dr. Kumar Visvanathan

Clinical Director of Medicine & Emergency Services, Co-Director of the Immunology Research Centre, St. Vincent's Hospital Melbourne, Australia

Dr. Tam C. Nguyen

Deputy Director of Research, St. Vincent’s Hospital Melbourne, Associate Professor, Melbourne Medical School, Adjunct Associate Professor (Research) Monash School of Public Health & Preventive Medicine, Australia

Sanjay Singh

Chief Executive Officer, Gennova Biopharmaceuticals, India

Kenneth Noonan Biotech Investment Summit

Kenneth Noonan

Chief Executive Officer, Lightstone Singapore

Anand Gautam

Executive Director & Emerging Science Lead APAC, Pfizer, Australia

Ke Wu

Chief Executive Officer, Bravovax, China

when & where

28 - 30 Oct 2020

Virtual Conference


Informa Connect is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more

COVID 19 Advisory from Informa
Learn More